[1]
|
吕华农, 刘文忠. 幽门螺旋杆菌感染及其相关疾病诊治[J]. 中华医学会, 2016, 6(1): 64-65.
|
[2]
|
Kusters, J.G., van Vliet, A.H. and Kuipers, E.J. (2006) Pathogenesis of Helicobacter pylori Infection. Clinical Microbiology Reviews, 19, 449-490.
|
[3]
|
Lin, J.X., Wang, W., Xie, J.-W., Wang, J.-B., Lu, J., Chen, Q.-Y., et al. (2018) Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging? Annals of Surgical Oncology, 28, 2703-2712. https://doi.org/10.1245/s10434-018-6634-z
|
[4]
|
赖慎伟, 丁克芬, 范秤来, 康晓峰, 朱树生, 黄建灵. 血清胃蛋白酶原胃泌素-17幽门螺杆菌14碳呼气试验联合检测在胃癌诊断中的应用效果[J]. 当代医学, 2019, 25(18): 81-83.
|
[5]
|
陆红梅, 吉布强, 严茂军. 根除幽门螺旋杆菌的三联疗法联合化疗治疗晚期胃癌的临床研究[J]. 山东医药, 2012, 51(48): 55-57.
|
[6]
|
Pormohammad, A., Ghotaslo, R., Leylabadlo, H.E., Nasiri, M.J., Dabiri, H. and Hashemi, A. (2018) Risk of Gastric Cancer in Association with Helicobacter pylori Different Virulence Factors: A Systematic Review and Meta-Analysis. Microbial Pathogenesis, 118, 214-219. https://doi.org/10.1016/j.micpath.2018.03.004
|
[7]
|
Leunk, R.D., Johnson, P.T., David, B.C., Kraft, W.G. and Morgan, D.R. (1988) Cytotoxin Activity in Broth-Culture Filtrates of Campylobacter pylori. Journal of Medi-cal Microbiology, 26, 93-99.
https://doi.org/10.1099/00222615-26-2-93
|
[8]
|
Li, J. and Guillermo, P.P. (2018) Is There a Role for the Non-Helicobacter pylori Bacteria in the Risk of Developing Gastric Cancer? International Journal of Molecular Sciences, 19, Article No. 1353.
https://doi.org/10.3390/ijms19051353
|
[9]
|
Zhai, J.M., An, Y.H., Wang, W., Fan, Y.G. and Yao, G.L. (2019) IL-32 Expression Indicates Unfavorable Prognosis in Patients with Colon Cancer. Oncology Letters, 17, 4655-4660.
|
[10]
|
郭辉, 程广坤, 张晓雪, 季洁如. 幽门螺旋杆菌感染与胃癌患者血清IL-1β, IL-8, IL-32的关系[J]. 海南医学, 2020, 31(18): 2326-2329.
|
[11]
|
Kim, H.J., Kim, N., Ji, H.P., Choi, S., Shin, C.M. and Lee, O.J. (2020) Helicobacter pylori Eradication Induced Constant Decrease in Interleukin-1B Expression over More than 5 Years in Patients with Gastric Cancer and Dysplasia. Gut and Liver, 14, 735-774. https://doi.org/10.5009/gnl19312
|
[12]
|
魏茜, 余树林, 黄宜峰. 胃癌组织中P53, IL-1β, NF-κB的表达及与幽门螺杆菌感染的相关性分析[J]. 中国中西医结合消化杂志, 2019, 27(3): 228-231.
|
[13]
|
张德志, 刘猛, 季节. 血清IL-8和IL-1β在胃癌患者中的水平变化及临床意义[J]. 中国卫生工程学, 2020, 19(1): 69-71.
|
[14]
|
Kiraly, A.J., Solimana, E., Jenkins, A. and Van Dross, R.T. (2015) Apigenin Inhibits COX-2, PGE2, and EP1 and also Initiates Terminal Differentiation in the Epidermis of Tumor Bearing Mice. Prosta-glandins Leukotrienes and Essential Fatty Acids, 104, 44-53. https://doi.org/10.1016/j.plefa.2015.11.006
|
[15]
|
路敏敏, 屈冬冬, 刘京运, 屈冬冬. 胃癌及癌前病变黏膜组织中环氧化酶-2, p53的表达及其与幽门螺杆菌感染的相关性[J]. 川北医学院学报, 2016, 31(3): 410-412.
|
[16]
|
Sergent, F., Hoffmann, P., Brouillet, S., Garnier, V., Salomon, A., Murthi, P., et al. (2016) Sustained Endocrine Gland-Derived Vascular Endothelial Growth Factor Levels Beyond the First Trimester of Pregnancy Display Phenotypic and Functional Changes Associated with the Pathogenesis of Pregnancy-Induced Hypertension. Hypertension, 68, 148-156. https://doi.org/10.1161/HYPERTENSIONAHA.116.07442
|
[17]
|
陈聪英, 杜海秋, 马骊, 姚皆帆, 刘燕. Hp-L型感染与MIF、MMP9、VEGF表达水平的关系研究[J]. 中华医院感染学杂志, 2019, 29(24): 3724-3728.
|
[18]
|
曹梦姣, 刘琳, 李慧艳, 党彤, 贾彦. MIF基因多态性与幽门螺杆菌感染及非贲门胃癌关系的研究[J]. 胃肠病学和肝病学杂志, 2017, 26(6): 693-69.
|
[19]
|
Meng, W., Bai, B., Sheng, L., Li, Y., Yue, P., Li, X., et al. (2015) Role of Hel-icobacter pylori in Gastric Cancer: Advances and Controversies. Discovery Medicine, 20, 285-293.
|
[20]
|
Yoon, K., Kim, N., Park, Y., Kim, B.K., Park, J.H., Shin, C.M., et al. (2019) Correlation between Macrophage Migration Inhibitory Factor and Autophagy in Helicobacter pylori-Associated gaStric Carcinogenesis. PLoS ONE, 14, Article ID: e021173. https://doi.org/10.1371/journal.pone.0211736
|
[21]
|
Butcher, L.D., Den Hartog, G., Ernst, P.B. and Crowe, S.E. (2017) Oxidative Stress Resulting from Helicobacter pylori Infection Contributes to Gastric Carcinogenesis. Cellular & Molecular Gastroenterology & Hepatology, 3, 316-322.
https://doi.org/10.1016/j.jcmgh.2017.02.002
|
[22]
|
Lee, D.Y., Jung, D.E., Yu, S.S., Lee, Y.S., Choi, B.K., Lee, Y.C., et al. (2017) Regulation of SIRT3 Signal Related Metabolic Reprogramming in Gastric Cancer by Helicobacter pylori Oncoprotein CagA. Oncotarget, 8, 78365-78378.
https://doi.org/10.18632/oncotarget.18695
|
[23]
|
杨静, 王军, 路红, 任茜, 王玉平, 关泉林, 等. 幽门螺杆菌通过胃癌干细胞诱导胃癌发生的机制[J]. 医学综述, 2021, 27(1):84-89.
|
[24]
|
廖阳, 鲁礼静, 刘巧庆, 岑朝. Hp感染致胃癌发病机制的研究进展[J]. 右江医学, 2022, 50(2):149-152.
|
[25]
|
Klutstein, M., Nejman, D., Greenfield, R. and Cedar, H. (2016) DNA Methylation in Cancer and Aging. Cancer Research, 76, 3446-3450. https://doi.org/10.1158/0008-5472.CAN-15-3278
|
[26]
|
da Costa, D.M., Neves-Filho, E.H.C., Alves, M.K. and Rabenhorst, S.H. (2013) Interleukin Polymorphisms and Differential Methylation Status in Gastric Cancer: An Associa-tion with Helicobacter pylori Infection. Epigenomics, 5, 167-175. https://doi.org/10.2217/epi.13.7
|
[27]
|
Kollmann, K., Briand, C., Bellutti, F., Schicher, N., Blunder, S., Zojer, M., et al. (2019) The Interplay of CDK4 and CDK6 in Mel-anoma. Oncotarget, 10, 1346-1359. https://doi.org/10.18632/oncotarget.26515
|
[28]
|
Bure, I.V., Nemtsova, M.V. and Zaletaev, D.V. (2019) Roles of E-Cadherin and Noncoding RNAs in the Epithelial-Mesenchymal Transition and Progression in Gastric Cancer. International Journal of Molecular Sciences, 20, Article No. 2870. https://doi.org/10.3390/ijms20122870
|
[29]
|
周法庭, 朱红玲, 朱华, 王毅, 许俊, 杨振华. 幽门螺杆菌诱导胃癌细胞上皮-间充质转化的研究[J]. 重庆医学, 2018, 47(27): 3485-3489.
|
[30]
|
Lecarpentier, Y., Schussler, O., Hébert, J.L. and Vallée, A. (2019) Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers. Frontiers in Oncolo-gy, 9, Article No. 1248. https://doi.org/10.3389/fonc.2019.01248
|
[31]
|
Serrano-Gomez, S.J., Maziveyi, M. and Alahari, S.K. (2016) Regulation of Epithelial-Mesenchymal Transition through Epigenetic and Post-Translational Modi-fications. Molecular Cancer, 15, Article No. 18.
https://doi.org/10.1186/s12943-016-0502-x
|
[32]
|
曾莎莎, 肖玲巧, 唐瑶, 段洁, 张洁雅, 李蕊, 等. 幽门螺杆菌Tipα通过Wnt/β-catenin通路诱导胃癌细胞EMT[J]. 中南医学科学杂志, 2020, 48(6):618-623.
|
[33]
|
袁丽, 于泳, 梅璐, 马颖光, 许晓芳, 杜君义, 等. 益生菌联合四联疗法对幽门螺杆菌感染补救治疗的疗效分析[J]. 中国微生态学杂志, 2017, 29(8):916-919.
|
[34]
|
周思君, 周小戈, 杨克戈. 益生菌治疗HP阳性慢性萎缩性胃炎的疗效及对HP根除率的影响[J]. 黑龙江医药, 2019, 32(3): 592-594.
|
[35]
|
Lee, C.Y., Shih, H.C., Yu, M.C., Lee, M.Y., Chang, Y.L., Lai, Y.Y., et al. (2017) Evaluation of the Potential Inhibitory Activity of a Combination of L. acidophilus, L. rhamnosus and L. sporogenes on Helicobacter pylori: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Chinese Journal of Integrative Medicine, 23, 176-182.
https://doi.org/10.1007/s11655-016-2531-0
|
[36]
|
Kentaro, S., Jan, T., Kuipers, E.J., Graham, D.Y., El-Omar, E.M., Miura, S., et al. (2015) Kyoto Global Consensus Report on Helicobacter pylori Gastritis. Gut, 64, 1353-1367. https://doi.org/10.1136/gutjnl-2015-309252
|
[37]
|
池肇春. 站在新的高度, 做好幽门螺旋杆菌感染的防治[J]. 世界华人消化杂志, 2016, 24(16): 2454-2462.
|
[38]
|
王建馗, 张福林. 幽门螺杆菌感染与胃癌化疗疗效的关系[J]. 世界华人消化杂志, 2014, 22(13): 1867-1870.
|
[39]
|
Lee, Y.C., Chiang, T.H., Chou, C.K., Tu, Y.K., Liao, W.C., Wu, M.S., et al. (2016) Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Re-view and Meta-Analysis. Gastroenterology, 150, 1113-1124. https://doi.org/10.1053/j.gastro.2016.01.028
|